Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AgeX Therapeutics, Inc. (AGE)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K10-K/A10-K/A
Revenues:  
    United States  0.00.11.21.00.8 
    Other  0.00.00.70.70.6 
Revenues   [+]0.00.11.91.71.41.1
            Revenue growth   [+]-76.4%-92.3%8.1%23.8%31.1% 
Cost of goods sold  0.00.00.20.20.40.0
Gross profit  0.00.11.71.51.01.1
            Gross margin  61.8%86.8%91.5%85.9%73.9%100.0%
Selling, general and administrative   [+]6.06.77.48.15.60.6
Research and development  1.01.55.05.95.8 
Other operating expenses   -0.2    
EBITDA   [+]  -9.4-11.9-9.9 
            EBITDA margin  -20126.5%-5344.4%-503.9%-689.2%-709.9%42.3%
Depreciation    0.70.10.1 
EBITA  -6.8-7.7-10.1-12.0-10.00.5
            EBITA margin  -20126.5%-5344.4%-541.3%-694.5%-714.0%42.3%
Amortization of intangibles  0.10.10.60.60.5 
EBIT   [+]-7.0-7.8-10.7-12.6-10.40.5
            EBIT margin  -20514.7%-5435.4%-571.3%-726.8%-748.2%42.3%
Non-recurring items   [+] 0.1  0.8 
Interest expense, net   [+]3.31.10.50.0-0.1 
Other income (expense), net   [+]20.817.70.00.33.4-0.5
Pre-tax income  10.58.7-11.1-12.2-7.70.0
Income taxes  21.017.4-0.20.1-0.20.0
            Tax rate  199.6%199.7%1.3% 3.0% 
Minority interest    -0.1-0.2-0.2 
Earnings from continuing ops  -10.5-8.6-10.9-12.2-7.5 
Earnings from discontinued ops   -0.1    
Net income  -10.5-8.7-10.9-12.2-7.50.0
            Net margin  -30947.1%-6031.3%-581.6%-703.4%-537.4%0.0%
   
Basic EPS   [+]($0.28)($0.23)($0.29)($0.33)($0.21) 
Diluted EPS   [+]($0.28)($0.23)($0.29)($0.33)($0.21) 
   
Shares outstanding (basic)   [+]37.937.937.737.334.9 
Shares outstanding (diluted)   [+]37.937.937.737.334.9 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy